D-0417-2025 Class II Ongoing

Recalled by L'Oreal USA — Clark, NJ

FDA drug recall D-0417-2025 was initiated by L'Oreal USA on Mar 5, 2025 and is designated Class II. Reason for recall: Chemical Contamination: This recall has been initiated due to detected trace levels of benzene. The recall status is ongoing. Affected quantity: 2,226,801 bottles.

Recall details

Product Type
Drugs
Report Date
May 21, 2025
Initiation Date
Mar 5, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2,226,801 bottles

Product description

La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.

Reason for recall

Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

Distribution pattern

Nationwide in the USA

Code information

Lot #: MYX46W, Exp 04/30/2025

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0417-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0417-2025. Report a data issue: hello@regdatalab.com.